Drug Shortage Report for TEVA-RABEPRAZOLE EC

Last updated on 2020-07-10 History
Report ID 106939
Drug Identification Number 02296632
Brand name TEVA-RABEPRAZOLE EC
Common or Proper name RABEPRAZOLE 10MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) RABEPRAZOLE SODIUM
Strength(s) 10MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2020-02-20
Estimated end date
Actual end date 2020-03-25
Shortage status Resolved
Updated date 2020-07-10
Company comments Item is discontinued.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2020-07-10 French Compare
v7 2020-07-10 English Compare
v6 2020-03-06 French Compare
v5 2020-03-06 English Compare
v4 2020-03-05 French Compare
v3 2020-03-05 English Compare
v2 2020-02-21 French Compare
v1 2020-02-21 English Compare